Linked Eye Condition

March 25, 2015 8:00 PM

4 0

WEDNESDAY, March 25, 2015 (HealthDay News) -- The U.S. Food and Drug Administration on Wednesday approved the use of Eylea, an injected drug, to treat diabetic retinopathy in patients with diabetic macular edema.

According to the U.S. Centers for Disease Control and Prevention, diabetic retinopathy is a leading cause of blindness in American adults. A third of those over 40 with diabetes have some form of the eye condition, according to 2008 data, the CDC said.

Also read: NFL playoff picture: Three divisions could be clinched in Week 14

Read more

To category page

Loading...